Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-25

Clinical Trial Update: Regional Prophylactic Vancomycin in Revision Total Knee Replacement [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update evaluating regional prophylactic vancomycin for preventing infection in revision total knee replacement; the study completed and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vancomycin (vancomycin)

Snippet

Sponsor: Mayo Clinic | Conditions: Arthropathy of Knee Joint | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2016-11-25